Xponance’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$633K Buy
6,153
+383
+7% +$24.9K ﹤0.01% 990
2026
Q1
$274K Buy
+5,770
New +$259K ﹤0.01% 1319
2025
Q3
Sell
-5,810
Closed -$214K 1569
2025
Q2
$214K Sell
5,810
-143
-2% -$4.94K ﹤0.01% 1296
2025
Q1
$234K Buy
5,953
+1,072
+22% +$48.3K ﹤0.01% 1204
2024
Q4
$227K Buy
4,881
+179
+4% +$8.09K ﹤0.01% 1246
2024
Q3
$212K Sell
4,702
-675
-13% -$32.1K ﹤0.01% 1228
2024
Q2
$265K Buy
+5,377
New +$219K ﹤0.01% 1086
2021
Q4
Sell
-2,220
Closed -$237K 1198
2021
Q3
$237K Sell
2,220
-366
-14% -$41.9K ﹤0.01% 1092
2021
Q2
$345K Buy
+2,586
New +$301K 0.01% 1039

Other funds holding TWST

Xponance's TWST Position: Q2 2026 in Review

Xponance increased its Twist Bioscience (TWST) stake by 6.6% in Q2 2026, buying an estimated $24.9K and bringing the position to 6,153 shares worth $633K. The position accounts for ﹤0.01% of the portfolio, ranked #990.

Xponance first reported a position in TWST in Q2 2021 and has held it in 9 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Xponance held 6,153 shares of Twist Bioscience worth $633K as of Q2 2026.
  • Xponance bought 383 Twist Bioscience shares in Q2 2026, an estimated $24.9K.
  • Twist Bioscience made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #990 holding.
  • Xponance first reported a position in Twist Bioscience in Q2 2021 and has held it in 9 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.